Meet Our Leadership Team

Our leadership team is tirelessly committed to disrupting cancer’s energy by bringing Misetionamide to market.

Clinical Opinion Leaders & Scientific Advisors

{{brizy_dc_image_alt imageSrc=

LISA GUTTMAN

Head, Clinical Operations

{{brizy_dc_image_alt imageSrc=

HANS POEHLER

Head, Pharmacology

{{brizy_dc_image_alt imageSrc=

ALEXANDER SMITH

Head, CMC & Quality

{{brizy_dc_image_alt imageSrc=

BEN STEINMETZ

Chief Commercial Officer

{{brizy_dc_image_alt imageSrc=

KATHRYN Martin, PharmD

Head, Scientific & Regulatory

Communications

{{brizy_dc_image_alt imageSrc=

Duane Sofia, PhD

Head, Non-Clinical Research

Collaborators

{{brizy_dc_image_alt imageSrc=
{{brizy_dc_image_alt imageSrc=
{{brizy_dc_image_alt imageSrc=

+1.610.922.1910

Copyright © 2025 Panavance Therapeutics Inc.

Our Home

About

Resources

Participate